IRIS
MOCCIA, MARCELLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.554
EU - Europa 1.514
AS - Asia 402
AF - Africa 69
SA - Sud America 4
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.547
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.504
IT - Italia 693
DE - Germania 215
CN - Cina 214
NL - Olanda 198
IE - Irlanda 88
UA - Ucraina 87
IN - India 73
CI - Costa d'Avorio 66
GB - Regno Unito 59
FI - Finlandia 54
CA - Canada 50
IR - Iran 49
VN - Vietnam 44
SE - Svezia 39
FR - Francia 27
ES - Italia 19
BG - Bulgaria 5
BE - Belgio 4
HK - Hong Kong 4
KR - Corea 4
SG - Singapore 4
TR - Turchia 4
AU - Australia 3
GR - Grecia 3
MK - Macedonia 3
PL - Polonia 3
RU - Federazione Russa 3
AR - Argentina 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
EG - Egitto 2
IQ - Iraq 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
BO - Bolivia 1
EU - Europa 1
HU - Ungheria 1
JP - Giappone 1
LI - Liechtenstein 1
LT - Lituania 1
MT - Malta 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
TH - Thailandia 1
UG - Uganda 1
VE - Venezuela 1
Totale 4.547
Salva come PNG Salva come JPEG
Città #
Chandler 610
Millbury 201
Amsterdam 195
Ashburn 153
Naples 133
Des Moines 129
Lawrence 119
Napoli 78
Nanjing 68
Beijing 65
Princeton 57
Boston 56
Wilmington 45
Dong Ket 44
Houston 43
Norwalk 40
Ottawa 36
Krefeld 34
Milan 24
Rome 22
Pune 21
Dublin 20
Rottweil 15
Dearborn 14
Hebei 14
Seattle 14
Cava De' Tirreni 12
Los Angeles 12
Nanchang 12
Washington 11
Jacksonville 10
Kronberg 9
Lappeenranta 9
Shenyang 9
Bari 8
Council Bluffs 8
Fairfield 8
Redwood City 8
Tianjin 8
Shenzhen 7
Turin 7
Augusta 6
Bilbao 6
Changsha 6
Mountain View 6
Vicenza 6
Woodbridge 6
Bagno A Ripoli 5
Caposele 5
Chengdu 5
Guangzhou 5
Montalbano Jonico 5
Qualiano 5
Rohtak 5
Sant'arpino 5
Sofia 5
Torino 5
Trento 5
Acerra 4
Ardabil 4
Boardman 4
Casoria 4
Como 4
Falls Church 4
Formia 4
Hong Kong 4
Jiaxing 4
London 4
Salerno 4
San Severino Marche 4
Stockholm 4
Toronto 4
Trapani 4
Ann Arbor 3
Bologna 3
Boscoreale 3
Brusciano 3
Brussels 3
Caserta 3
Catania 3
Edinburgh 3
Forino 3
Frankfurt am Main 3
Hangzhou 3
Menlo Park 3
New Delhi 3
Serre 3
Skopje 3
Torre Annunziata 3
Vermezzo 3
Wuhan 3
Ankara 2
Arcore 2
Benevento 2
Bitonto 2
Cairo 2
Capodrise 2
Carbonia 2
Darmstadt 2
Ferrara 2
Totale 2.611
Salva come PNG Salva come JPEG
Nome #
AQP4-MOG Double-Positive Neuromyelitis Optica Spectrum Disorder: Case Report with Central and Peripheral Nervous System Involvement and Review of Literature 156
Quality of Life and Cognitive function in pediatric and young adults multiple sclerosis: a cross-sectional study 124
Apathy in untreated, de novo patients with Parkinson's disease: validation study of Apathy Evaluation Scale. 81
Uric acid in relapsing–remitting multiple sclerosis: a 2-year longitudinal study 71
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson's disease. 67
Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis 62
2D linear measures of ventricular enlargement may be relevant markers of brain atrophy and long-term disability progression in multiple sclerosis 62
Speech discrimination is impaired in parkinsonian patients: Expanding the audiologic findings of Parkinson's disease 61
Quality of life and cognitive function in pediatric and young multiple sclerosis patients: a cross-sectional study 57
MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis 56
Impulsive-compulsive behaviors in parkin-associated Parkinson disease 55
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 53
The Heterogeneity of Early Parkinson?s Disease: A Cluster Analysis on Newly Diagnosed Untreated Patients 52
Persistence, adherence, healthcare resource utilisation and costs for interferon Beta in multiple sclerosis: a population-based study in the Campania region (southern Italy) 52
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 50
A 8-year retrospective cohort study comparing Interferon-beta formulations for relapsing-remitting multiple sclerosis 49
Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre study 47
The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests 43
Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026 43
White matter changes and the development of motor phenotypes in de novo Parkinson's Disease 42
Immunometabolic profiling of patients with multiple sclerosis identifies new biomarkers to predict disease activity during treatment with interferon beta-1a 42
Generalised boundary shift integral for longitudinal assessment of spinal cord atrophy 42
Uric acid: a potential biomarker of multiple sclerosis and of its disability 41
Can people with multiple sclerosis actually understand what they read in the Internet age? 41
Quitting smoking: An early non-motor feature of Parkinson's disease? 40
CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patients 40
Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple Sclerosis 40
Normative values of the Rao’s Brief Repeatable Battery in an Italian young adolescent population: the influence of age, gender, and education 40
A 8-year retrospective cohort study comparing Interferon-β formulations for relapsing-remitting multiple sclerosis 40
Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression 39
COVID-19 prevention and multiple sclerosis management: The SAFE pathway for the post-peak 38
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 38
A longitudinal real-life comparison study of natalizumab and fingolimod 37
Gender and non motor fluctuations in Parkinson's disease: A prospective study 37
Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairment 37
How many injections did you miss last month? A simple question to predict interferon β-1a adherence in multiple sclerosis 36
Predictors of long-term interferon discontinuation in newly diagnosed relapsing multiple sclerosis 36
Retinal vascular density in multiple sclerosis: a one year follow up 36
Presence and progression of non-motor symptoms in relation to uric acid in de novo Parkinson's disease 35
Botulinum toxin for the management of spasticity in multiple sclerosis: the Italian botulinum toxin network study 35
Mild or no COVID-19 symptoms in cladribine-treated multiple sclerosis: Two cases and implications for clinical practice 35
Adherence to anti-Parkinson drug therapy in the "rEASON" sample of Italian patients with Parkinson's disease: The linguistic validation of the Italian version of the "morisky Medical Adherence scale-8 items" 34
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 33
Season of birth and Parkinson’s disease: possible relationship? 33
The impact of diagnostic criteria and treatments on the 20-year costs for treating relapsing-remitting multiple sclerosis 33
Changes in lymphocytes, neutrophils and immunoglobulins in year-1 cladribine treatment in multiple sclerosis 32
Grey:white matter ratio at diagnosis and the risk of 10-year multiple sclerosis progression 32
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients 32
Are granular osmiophilic material deposits an epiphenomenon in CADASIL? 32
Uric acid relates to dopamine transporter availability in Parkinson's disease 32
Validation of the Italian version of the Multiple Sclerosis Intimacy and Sexuality Questionnaire-19 32
The importance of being persistent to multiple sclerosis treatments 31
Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare delivery 31
Restless legs syndrome is a common feature of adult celiac disease. 30
The Framingham cardiovascular risk score in multiple sclerosis 30
e-Health and multiple sclerosis: An update 30
Peripapillary Vessel Density as Early Biomarker in Multiple Sclerosis 30
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 29
Health-care disparities stemming from sexual orientation of Italian patients with Multiple Sclerosis: A cross-sectional web-based study 29
Healthcare Costs for Treating Relapsing Multiple Sclerosis and the Risk of Progression: A Retrospective Italian Cohort Study from 2001 to 2015 29
Clinical variables associated with treatment changes in Parkinson's disease: results from the longitudinal phase of the REASON study 29
Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting 29
Unraveling diagnostic uncertainty in transition phase from relapsing-remitting to secondary progressive multiple sclerosis 29
Physical Exercise Moderates the Effects of Disability on Depression in People with Multiple Sclerosis during the COVID-19 Outbreak 29
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 28
Increased endothelin-1 serum levels in patients with multiple sclerosis 27
Cognitive trajectories in multiple sclerosis: a long-term follow-up study 27
Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studies 27
Association Between Institutional Affiliations of Academic Editors and Authors in Medical Journals 27
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 26
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 26
How does smoking affect olfaction in Parkinson's disease? 26
Biomarkers of Parkinson's disease: recent insights, current challenges, and future prospects 26
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France 25
The Dress: Transforming a web viral event into a scientific survey 25
JCV antibodies index on natalizumab treatment: fluctuations and seroconversion. 25
A four-year longitudinal study on restless legs syndrome in Parkinson disease 25
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 25
Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease - Report of the JPND Working Group BioLoC-PD 25
COVID-19 pandemic and mental distress in Multiple Sclerosis: implications for clinical management 25
Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems group 25
Determinants of early working impairments in multiple sclerosis 24
Cardiovascular profile improvement during Natalizumab treatment 24
Olfactory function and cognition in relapsing–remitting and secondary-progressive multiple sclerosis 24
Advances in spinal cord imaging in multiple sclerosis 24
Risk of invasive fungal infections among patients treated with disease modifying treatments for multiple sclerosis: a comprehensive review 24
A retrospective exploratory analysis on cardiovascular risk and cognitive dysfunction in multiple sclerosis 23
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis 22
Google Trends: New evidence for seasonality of multiple sclerosis 22
Non-motor correlates of smoking habits in de novo Parkinson's disease 22
Abnormal eating behaviors in progressive supranuclear palsy 22
Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson's Disease 22
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease 22
The Heterogeneity of Early Parkinson's Disease: A Cluster Analysis on Newly Diagnosed Untreated Patients 22
Mental Health in Multiple Sclerosis During the COVID-19 Outbreak: A Delicate Balance between Fear of Contagion and Resilience 22
Monocular Diplopia in Idiopathic Intracranial Hypertension: A Case Report and Literature Review 22
JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level. 21
Optical coherence tomography angiography retinal vascular network assessment in multiple sclerosis 21
Ocrelizumab depletes T-lymphocytes more than rituximab in multiple sclerosis 21
Interplay Between Cognitive and Bowel/Bladder Function in Multiple Sclerosis 21
Totale 3.663
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.723
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.723
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201926 0 0 0 0 0 0 0 0 0 13 9 4
2019/2020576 122 37 139 17 15 52 16 28 10 60 62 18
2020/2021483 36 21 35 83 94 45 15 13 32 14 35 60
2021/2022974 12 2 6 15 17 90 11 33 87 99 183 419
2022/20231.717 185 118 33 117 161 252 166 121 242 194 99 29
2023/2024793 43 159 133 57 53 113 77 110 24 24 0 0
Totale 5.063